Skip to main content
Erschienen in: World Journal of Surgery 2/2020

09.08.2019 | Original Scientific Report

Comparison of Pre- and Post-transplant Parathyroidectomy in Renal Transplant Recipients and the Impact of Parathyroidectomy Timing on Calcium Metabolism and Renal Allograft Function: A Retrospective Single-Center Analysis

verfasst von: Manabu Okada, Takahisa Hiramitsu, Toshihiro Ichimori, Norihiko Goto, Shunji Narumi, Yoshihiko Watarai, Tetsuhiko Sato, Yoshihiro Tominaga

Erschienen in: World Journal of Surgery | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

The effect of parathyroidectomy (PTx) timing on serum calcium (Ca) levels and renal functions in renal transplant recipients with severe hyperparathyroidism (HPT) remains unclear. We retrospectively aimed to investigate and compare the clinical data of patients who underwent pre- and post-transplant PTx and elucidated the impact of PTx timing on serum Ca levels and renal graft outcomes after renal transplantation (RTx).

Methods

During January 2000–December 2016, 53 and 55 patients underwent post-transplant PTx (Post-RTx group) and pretransplant PTx (Pre-RTx group), respectively. The serum Ca levels and estimated glomerular filtration rate (eGFR) were assessed in both groups.

Results

At the end of the follow-up, the serum Ca levels were significantly higher and the incidence of hypocalcemia was significantly lower in the Pre-RTx group than in the Post-RTx group [9.5 vs. 8.9 mg/dL, P < 0.001; 14.5% vs. 34.0%, P = 0.024]. The decrease in the eGFR 12–36 months after RTx was more significant in the Post-RTx group than in the Pre-RTx group (−13.8% vs. −0.9%; P = 0.001). A logistic regression involving age, sex, dialysis period, and serum parathormone level revealed that post-transplant PTx is an independent risk factor for persistent hypocalcemia at the end of the follow-up (P = 0.034) and for a >20% decrease in the eGFR 12–36 months after RTx (P = 0.029).

Conclusions

In renal transplant candidates with severe HPT, pretransplant PTx should be considered to prevent persistent hypocalcemia and deterioration of the renal graft function.
Literatur
1.
Zurück zum Zitat Block GA, Klassen PS, Lazarus JM et al (2004) Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15:2208–2218CrossRef Block GA, Klassen PS, Lazarus JM et al (2004) Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15:2208–2218CrossRef
2.
Zurück zum Zitat Reinhardt W, Bartelworth H, Jockenhövel F et al (1998) Sequential changes of biochemical bone parameters after kidney transplantation. Nephrol Dial Transpl 13:436–442CrossRef Reinhardt W, Bartelworth H, Jockenhövel F et al (1998) Sequential changes of biochemical bone parameters after kidney transplantation. Nephrol Dial Transpl 13:436–442CrossRef
3.
Zurück zum Zitat Pihlstrøm H, Dahle DO, Mjøen G et al (2015) Increased risk of all-cause mortality and renal graft loss in stable renal transplant recipients with hyperparathyroidism. Transplantation 99:351–359CrossRef Pihlstrøm H, Dahle DO, Mjøen G et al (2015) Increased risk of all-cause mortality and renal graft loss in stable renal transplant recipients with hyperparathyroidism. Transplantation 99:351–359CrossRef
4.
Zurück zum Zitat Bleskestad IH, Bergrem H, Leivestad T et al (2014) Parathyroid hormone and clinical outcome in kidney transplant patients with optimal transplant function. Clin Transpl 28:479–486CrossRef Bleskestad IH, Bergrem H, Leivestad T et al (2014) Parathyroid hormone and clinical outcome in kidney transplant patients with optimal transplant function. Clin Transpl 28:479–486CrossRef
5.
Zurück zum Zitat Evenepoel P, Claes K, Kuypers DR et al (2007) Parathyroidectomy after successful kidney transplantation: a single centre study. Nephrol Dial Transpl 22:1730–1737CrossRef Evenepoel P, Claes K, Kuypers DR et al (2007) Parathyroidectomy after successful kidney transplantation: a single centre study. Nephrol Dial Transpl 22:1730–1737CrossRef
6.
Zurück zum Zitat Schwarz A, Rustien G, Merkel S et al (2007) Decreased renal transplant function after parathyroidectomy. Nephrol Dial Transpl 22:584–591CrossRef Schwarz A, Rustien G, Merkel S et al (2007) Decreased renal transplant function after parathyroidectomy. Nephrol Dial Transpl 22:584–591CrossRef
7.
Zurück zum Zitat Evenepoel P, Claes K, Kuypers D et al (2005) Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single centre study. Nephrol Dial Transpl 20:1714–1720CrossRef Evenepoel P, Claes K, Kuypers D et al (2005) Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single centre study. Nephrol Dial Transpl 20:1714–1720CrossRef
8.
Zurück zum Zitat Littbarski SA, Kaltenborn A, Gwiasda J et al (2018) Timing of parathyroidectomy in kidney transplant candidates with secondary hyperparathryroidism: effect of pretransplant versus early or late post-transplant parathyroidectomy. Surgery 163:373–380CrossRef Littbarski SA, Kaltenborn A, Gwiasda J et al (2018) Timing of parathyroidectomy in kidney transplant candidates with secondary hyperparathryroidism: effect of pretransplant versus early or late post-transplant parathyroidectomy. Surgery 163:373–380CrossRef
9.
Zurück zum Zitat Jeon HJ, Kim YJ, Kwon HY et al (2012) Impact of parathyroidectomy on allograft outcomes in kidney transplantation. Transpl Int 25:1248–1256CrossRef Jeon HJ, Kim YJ, Kwon HY et al (2012) Impact of parathyroidectomy on allograft outcomes in kidney transplantation. Transpl Int 25:1248–1256CrossRef
10.
Zurück zum Zitat Guideline Working Group, Japanese Society for Dialysis therapy (2008) Clinical practice guideline for the management of secondary hyperparathyroidism. Ther Apher Dial 6:514–525CrossRef Guideline Working Group, Japanese Society for Dialysis therapy (2008) Clinical practice guideline for the management of secondary hyperparathyroidism. Ther Apher Dial 6:514–525CrossRef
11.
Zurück zum Zitat Haas M, Sis B, Racusen LC et al (2014) Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transpl 14:272–283CrossRef Haas M, Sis B, Racusen LC et al (2014) Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transpl 14:272–283CrossRef
12.
Zurück zum Zitat Matsuo S, Imai E, Horio M et al (2009) Revised Equations for estimating glomerular filtration rate (GFR) from serum creatinine in Japan. Am J Kidney Dis 53:982–992CrossRef Matsuo S, Imai E, Horio M et al (2009) Revised Equations for estimating glomerular filtration rate (GFR) from serum creatinine in Japan. Am J Kidney Dis 53:982–992CrossRef
13.
Zurück zum Zitat Cruzado JM, Moreno P, Torregrosa JV et al (2016) A randomized study comparing parathyroidectomy with cinacalcet for treating hypercalcemia in kidney allograft recipients with hyperparathyroidism. J Am Soc Nephrol 27:2487–2494CrossRef Cruzado JM, Moreno P, Torregrosa JV et al (2016) A randomized study comparing parathyroidectomy with cinacalcet for treating hypercalcemia in kidney allograft recipients with hyperparathyroidism. J Am Soc Nephrol 27:2487–2494CrossRef
14.
Zurück zum Zitat Chertow GM, Block GA, Correa-Rotter R et al (2012) Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med 367:2484–2494 Chertow GM, Block GA, Correa-Rotter R et al (2012) Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med 367:2484–2494
15.
Zurück zum Zitat Komaba H, Taniguchi M, Wada A et al (2015) Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism. Kidney Int 88:350–359CrossRef Komaba H, Taniguchi M, Wada A et al (2015) Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism. Kidney Int 88:350–359CrossRef
16.
Zurück zum Zitat Lee HH, Kim AJ, Ro H et al (2016) Sequential changes of vitamin D level and parathyroid hormone after kidney transplantation. Transpl Proc 48:897–899CrossRef Lee HH, Kim AJ, Ro H et al (2016) Sequential changes of vitamin D level and parathyroid hormone after kidney transplantation. Transpl Proc 48:897–899CrossRef
17.
Zurück zum Zitat Slatopolsky E, Finch J, Clay P et al (2000) A novel mechanism for skeletal resistance in uremia. Kidney Int 58:753–761CrossRef Slatopolsky E, Finch J, Clay P et al (2000) A novel mechanism for skeletal resistance in uremia. Kidney Int 58:753–761CrossRef
18.
Zurück zum Zitat Åkerström G, Stålberg P, Surgical Management of Multiglandular Parathyroid Disease (2013) In: Randolph G (ed) Surgery of the thyroid and parathyroid glands, 2nd edn. Elsevier, Philadelphia, pp 620–638 Åkerström G, Stålberg P, Surgical Management of Multiglandular Parathyroid Disease (2013) In: Randolph G (ed) Surgery of the thyroid and parathyroid glands, 2nd edn. Elsevier, Philadelphia, pp 620–638
19.
Zurück zum Zitat Benz RL, Schleifer CR, Teehan BP et al (1989) Successful treatment of postparathyroidectomy hypocalcemia using continuous ambulatory intraperitoneal calcium (CAIC) therapy. Perit Dial Int. 9:285–288PubMed Benz RL, Schleifer CR, Teehan BP et al (1989) Successful treatment of postparathyroidectomy hypocalcemia using continuous ambulatory intraperitoneal calcium (CAIC) therapy. Perit Dial Int. 9:285–288PubMed
20.
Zurück zum Zitat Gutierrez O, Isakova T, Rhee E et al (2005) Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol 16:2205–2215CrossRef Gutierrez O, Isakova T, Rhee E et al (2005) Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol 16:2205–2215CrossRef
21.
Zurück zum Zitat Saito H, Kusano K, Kinosaki M et al (2003) Human fibroblast growth factor-23 mutants suppress Na+-dependent phosphate co-transport activity and 1alpha,25-dihydroxyvitamin D3 production. J Biol Chem 278:2206–2211CrossRef Saito H, Kusano K, Kinosaki M et al (2003) Human fibroblast growth factor-23 mutants suppress Na+-dependent phosphate co-transport activity and 1alpha,25-dihydroxyvitamin D3 production. J Biol Chem 278:2206–2211CrossRef
22.
Zurück zum Zitat Hsu CH, Patel SR, Young EW et al (1994) The biological action of calcitriol in renal failure. Kidney Int 46:605–612CrossRef Hsu CH, Patel SR, Young EW et al (1994) The biological action of calcitriol in renal failure. Kidney Int 46:605–612CrossRef
23.
Zurück zum Zitat Hamdy NA, Kanis JA, Beneton MN et al (1995) Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure. BMJ 310:358–363CrossRef Hamdy NA, Kanis JA, Beneton MN et al (1995) Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure. BMJ 310:358–363CrossRef
24.
Zurück zum Zitat Rix M, Eskildsen P, Olgaard K (2004) Effect of 18 months of treatment with alfacalcidol on bone in patients with mild to moderate chronic renal failure. Nephrol Dial Transpl 19:870–876CrossRef Rix M, Eskildsen P, Olgaard K (2004) Effect of 18 months of treatment with alfacalcidol on bone in patients with mild to moderate chronic renal failure. Nephrol Dial Transpl 19:870–876CrossRef
25.
Zurück zum Zitat Coyne D, Acharya M, Qiu P et al (2006) Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD. Am J Kidney Dis 47:263–276CrossRef Coyne D, Acharya M, Qiu P et al (2006) Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD. Am J Kidney Dis 47:263–276CrossRef
27.
Zurück zum Zitat Dreyer P, Ohe MN, Santos LM et al (2016) Parathyroid responsiveness during hypocalcemia after total parathyroidectomy and autotransplantation in patients with renal hyperparathyroidism. J Bras Nefrol 38:183–190CrossRef Dreyer P, Ohe MN, Santos LM et al (2016) Parathyroid responsiveness during hypocalcemia after total parathyroidectomy and autotransplantation in patients with renal hyperparathyroidism. J Bras Nefrol 38:183–190CrossRef
28.
Zurück zum Zitat Massfelder T, Parekh N, Endlich K et al (1996) Effect of intrarenally infused parathyroid hormone-related protein on renal blood flow and glomerular filtration rate in the anaesthetized rat. Br J Pharmacol 118:1995–2000CrossRef Massfelder T, Parekh N, Endlich K et al (1996) Effect of intrarenally infused parathyroid hormone-related protein on renal blood flow and glomerular filtration rate in the anaesthetized rat. Br J Pharmacol 118:1995–2000CrossRef
29.
Zurück zum Zitat de Zeeuw D, Agarwal R, Amdahl M et al (2010) Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. Lancet 376:1543–1551CrossRef de Zeeuw D, Agarwal R, Amdahl M et al (2010) Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. Lancet 376:1543–1551CrossRef
30.
Zurück zum Zitat Andreev E, Koopman M, Arisz L (1999) A rise in plasma creatinine that is not a sign of renal failure: which drugs can be responsible? J Intern Med 246:247–252CrossRef Andreev E, Koopman M, Arisz L (1999) A rise in plasma creatinine that is not a sign of renal failure: which drugs can be responsible? J Intern Med 246:247–252CrossRef
31.
Zurück zum Zitat Parikh S, Nagaraja H, Agarwal A et al (2013) Impact of post-kidney transplant parathyroidectomy on allograft function. Clin Transpl 27:397–402CrossRef Parikh S, Nagaraja H, Agarwal A et al (2013) Impact of post-kidney transplant parathyroidectomy on allograft function. Clin Transpl 27:397–402CrossRef
32.
Zurück zum Zitat Rosen S, Greenfeld Z, Bernheim J et al (1990) Hypercalcemic nephropathy: chronic disease with predominant medullary inner stripe injury. Kidney Int 37:1067–1075CrossRef Rosen S, Greenfeld Z, Bernheim J et al (1990) Hypercalcemic nephropathy: chronic disease with predominant medullary inner stripe injury. Kidney Int 37:1067–1075CrossRef
33.
Zurück zum Zitat Peacock M (2002) Primary hyperparathyroidism and the kidney: biochemical and clinical spectrum. J Bone Miner Res 17:87–94 Peacock M (2002) Primary hyperparathyroidism and the kidney: biochemical and clinical spectrum. J Bone Miner Res 17:87–94
34.
Zurück zum Zitat Henegar JR, Coleman JP, Cespedes J et al (2003) Glomerular calcification in hypercalcemic nephropathy. Arch Pathol Lab Med 127:80–85 Henegar JR, Coleman JP, Cespedes J et al (2003) Glomerular calcification in hypercalcemic nephropathy. Arch Pathol Lab Med 127:80–85
35.
Zurück zum Zitat Suh JM, Cronan JJ, Monchik JM (2008) Primary hyperparathyroidism: is there an increased prevalence of renal stone disease? AJR Am J Roentgenol 191:908–911CrossRef Suh JM, Cronan JJ, Monchik JM (2008) Primary hyperparathyroidism: is there an increased prevalence of renal stone disease? AJR Am J Roentgenol 191:908–911CrossRef
37.
Zurück zum Zitat Evenepoel P, Claes K, Kuypers D et al (2004) Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study. Nephrol Dial Transpl 19:1281–1287CrossRef Evenepoel P, Claes K, Kuypers D et al (2004) Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study. Nephrol Dial Transpl 19:1281–1287CrossRef
38.
Zurück zum Zitat Evenepoel P, Kuypers D, Maes B et al (2001) Persistent hyperparathyroidism after kidney transplantation requiring parathyroidectomy. Acta Otorhinolaryngol Belg 55:17–186 Evenepoel P, Kuypers D, Maes B et al (2001) Persistent hyperparathyroidism after kidney transplantation requiring parathyroidectomy. Acta Otorhinolaryngol Belg 55:17–186
39.
Zurück zum Zitat Nakai K, Fujii H, Ishimura T et al (2017) Incidence and Risk Factors of Persistent Hyperparathyroidism After Kidney Transplantation. Transplant Proc. 49:53–56CrossRef Nakai K, Fujii H, Ishimura T et al (2017) Incidence and Risk Factors of Persistent Hyperparathyroidism After Kidney Transplantation. Transplant Proc. 49:53–56CrossRef
40.
Zurück zum Zitat Kikumori Imai T, Tanaka Y et al (1999) Parathyroid autotransplantation with total thyroidectomy for thyroid carcinoma: long-term follow-up of grafted parathyroid function. Surgery 125:504–508CrossRef Kikumori Imai T, Tanaka Y et al (1999) Parathyroid autotransplantation with total thyroidectomy for thyroid carcinoma: long-term follow-up of grafted parathyroid function. Surgery 125:504–508CrossRef
42.
Zurück zum Zitat Tominaga Y, Katayama A, Sato T, et al (2003) Re-operation is frequently required when parathyroid glands remain after initial parathyroidectomy for advanced secondary hyperparathyroidism in uraemic patients. Nephrol Dial Transplant. 18 Suppl 3:iii65–70CrossRef Tominaga Y, Katayama A, Sato T, et al (2003) Re-operation is frequently required when parathyroid glands remain after initial parathyroidectomy for advanced secondary hyperparathyroidism in uraemic patients. Nephrol Dial Transplant. 18 Suppl 3:iii65–70CrossRef
Metadaten
Titel
Comparison of Pre- and Post-transplant Parathyroidectomy in Renal Transplant Recipients and the Impact of Parathyroidectomy Timing on Calcium Metabolism and Renal Allograft Function: A Retrospective Single-Center Analysis
verfasst von
Manabu Okada
Takahisa Hiramitsu
Toshihiro Ichimori
Norihiko Goto
Shunji Narumi
Yoshihiko Watarai
Tetsuhiko Sato
Yoshihiro Tominaga
Publikationsdatum
09.08.2019
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 2/2020
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-019-05124-6

Weitere Artikel der Ausgabe 2/2020

World Journal of Surgery 2/2020 Zur Ausgabe

Presidential Address

Mastery in Endocrine Surgery

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.